Logo

New England Biolabs: Jim Ellard, Sal Russello

Jul 07, 2022

Jim Ellard, CEO Of New England Biolabs, will retire Aug. 15. He will be succeeded by Salvatore (Sal) Russello, currently NEB's director of OEM & customized solutions. Ellard, who joined NEB in 1984 as a summer intern and became the firm's CEO in 2005, will remain chairman of the board of directors. Russello joined NEB in 2007 as associate director of business development and assumed his current role in 2017. Prior to NEB, he was director of reagent marketing at Caliper Life Sciences, now part of PerkinElmer, and before that, business development manager at Cell Signaling Technology.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.